Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1b, Open-Label, Exploratory Biomarker Basket Study of S-4321 in Participants With an Autoimmune or Immune-Mediated Disease

NCT07455578 is registered in ClinicalTrials.gov with Seismic Therapeutic AU Pty Ltd as lead sponsor.

NCT NCT07455578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07455578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1b, Open-Label, Exploratory Biomarker Basket Study of S-4321 in Participants With an Autoimmune or Immune-Mediated Disease
Lead sponsor
Seismic Therapeutic AU Pty Ltd
Phase
Phase 1
Overall status
Recruiting
Start date
June 30, 2026
Completion date
September 30, 2027
Enrollment
24 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis (ad), autoimmune diseases, cutaneous lupus erythematosus (cle), psoriasis (pso), psoriatic arthritis (psa), rheumatoid arthritis (ra)